Search research articles
Contact Us
Filters
Showing results (411-420 of 461) with videos related to
Page
of 47
Sort By:
Schizophrenia Research
|
March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET study
Shinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
Journal of Psychiatric Research
|
August 20, 2025
The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study
Kengo Yonezawa, Shinichiro Nakajima, Nobuaki Hondo, et al.
Journal of Psychiatry & Neuroscience : JPN
|
January 14, 2022
Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
Ryo Ochi, Eric Plitman, Raihaan Patel, et al.
Neuropsychopharmacology Reports
|
March 18, 2020
Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia
Kamiyu Ogyu, Yoshihiro Noda, Kazunari Yoshida, et al.
The Journal of Clinical Psychiatry
|
January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia
Yusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Cancer Science
|
August 5, 2020
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
Nayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
BMC Oral Health
|
August 21, 2012
Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey
Hideaki Tani, Hiroyuki Uchida, Takefumi Suzuki, et al.
British Journal of Neurosurgery
|
October 15, 2014
Improvement in treatment results of glioblastoma over the last three decades and beneficial factors
Hiroto Kawano, Hirofumi Hirano, Hajime Yonezawa, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 7, 2026
Hierarchical Brain Dynamics Associated with Remission from Major Depression Across Diverse Therapeutic Modalities
Kazushi Shinagawa, Jinichi Hirano, Yuki Kobayashi, et al.
Neuropsychopharmacology Reports
|
April 30, 2026
Glutathione-Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta-Analysis
Takahide Etani, Nobuaki Hondo, Sho Moriguchi, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 461) with videos related to
Sort By:
Page
of 47
Schizophrenia Research
|
March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET study
Shinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
Journal of Psychiatric Research
|
August 20, 2025
The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study
Kengo Yonezawa, Shinichiro Nakajima, Nobuaki Hondo, et al.
Journal of Psychiatry & Neuroscience : JPN
|
January 14, 2022
Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
Ryo Ochi, Eric Plitman, Raihaan Patel, et al.
Neuropsychopharmacology Reports
|
March 18, 2020
Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia
Kamiyu Ogyu, Yoshihiro Noda, Kazunari Yoshida, et al.
The Journal of Clinical Psychiatry
|
January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia
Yusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Cancer Science
|
August 5, 2020
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
Nayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
BMC Oral Health
|
August 21, 2012
Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey
Hideaki Tani, Hiroyuki Uchida, Takefumi Suzuki, et al.
British Journal of Neurosurgery
|
October 15, 2014
Improvement in treatment results of glioblastoma over the last three decades and beneficial factors
Hiroto Kawano, Hirofumi Hirano, Hajime Yonezawa, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 7, 2026
Hierarchical Brain Dynamics Associated with Remission from Major Depression Across Diverse Therapeutic Modalities
Kazushi Shinagawa, Jinichi Hirano, Yuki Kobayashi, et al.
Neuropsychopharmacology Reports
|
April 30, 2026
Glutathione-Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta-Analysis
Takahide Etani, Nobuaki Hondo, Sho Moriguchi, et al.
Page
of 47